FDA Inspection 1130823 — Joseph Thaddeus Beck, MD

Joseph Thaddeus Beck, MD — FEI 3003530911

The FDA completed an inspection of Joseph Thaddeus Beck, MD on October 2, 2020 in Springdale, AR. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 2, 2020
Fiscal Year
2021
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Springdale, AR (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
752621 CFR 312.62(a)Accountability records
756021 CFR 312.60FD-1572, protocol compliance